当前位置:首页 - 行情中心 - 三星医疗(601567) - 财务分析 - 现金流量表

三星医疗

(601567)

  

流通市值:320.81亿  总市值:320.82亿
流通股本:14.05亿   总股本:14.05亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,888,848,435.022,741,447,437.4315,517,191,375.89,043,676,966.55
  收取利息、手续费及佣金的现金371,773.41371,773.418,198,467.887,549,957.51
  收到的税费返还128,684,259.3887,933,740.32243,703,655.47182,124,199.13
  收到其他与经营活动有关的现金364,543,548.44204,564,723.94587,687,228.88555,127,653.6
  经营活动现金流入小计6,382,448,016.253,034,317,675.116,356,780,728.039,788,478,776.79
  购买商品、接受劳务支付的现金3,490,583,553.221,627,316,484.059,673,876,374.164,614,951,843.48
  支付给职工以及为职工支付的现金1,246,861,868.74658,773,904.952,288,028,799.131,669,361,152.46
  支付的各项税费516,224,026.99269,292,461.15987,641,716.58821,746,121.69
  支付其他与经营活动有关的现金1,188,034,844.24627,369,103.431,571,049,394.51,653,207,701.91
  经营活动现金流出小计6,441,704,293.193,182,751,953.5814,520,596,284.378,759,266,819.54
  经营活动产生的现金流量净额-59,256,276.94-148,434,278.481,836,184,443.661,029,211,957.25
二、投资活动产生的现金流量:
  收回投资收到的现金5,253,741,480.833,592,140,912.941,549,603,700.61276,870,680.81
  取得投资收益收到的现金26,769,194.073,701,254.4698,917,856.380,035,760.96
  处置固定资产、无形资产和其他长期资产收回的现金净额14,355,433.6-1,420,909.98112,368.25
  处置子公司及其他营业单位收到的现金净额-3,000,000--
  投资活动现金流入小计5,294,866,108.53,598,842,167.41,649,942,466.89357,018,810.02
  购建固定资产、无形资产和其他长期资产支付的现金503,237,075.76273,482,236.691,044,557,836.57710,227,199.75
  投资支付的现金4,557,710,218.633,864,654,752.182,629,805,673.57285,406,228.64
  取得子公司及其他营业单位支付的现金--2,317,767.592,317,767.59
  投资活动现金流出小计5,060,947,294.394,138,136,988.873,676,681,277.73997,951,195.98
  投资活动产生的现金流量净额233,918,814.11-539,294,821.47-2,026,738,810.84-640,932,385.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金64,250,00035,000,000124,767,840.2117,479,270.93
  其中:子公司吸收少数股东投资收到的现金--124,767,840.223,000,000
  取得借款收到的现金1,302,205,356.4-4,000,000,000559,454,457.03
  收到其他与筹资活动有关的现金99,865,151.68151,824,435.7243,491,583.5314,180,550.74
  筹资活动现金流入小计1,466,320,508.08186,824,435.724,168,259,423.7991,114,278.7
  偿还债务支付的现金1,908,847,777.771,370,842.813,450,000,0002,648,683,823.24
  分配股利、利润或偿付利息支付的现金1,286,018,586.0816,694,238.89956,283,479.22945,546,809.28
  其中:子公司支付给少数股东的股利、利润1,826,000-3,157,208.291,832,000
  支付其他与筹资活动有关的现金128,109,653.9172,854,336.76391,189,801.55609,959,569.13
  筹资活动现金流出小计3,322,976,017.7690,919,418.464,797,473,280.774,204,190,201.65
  筹资活动产生的现金流量净额-1,856,655,509.6895,905,017.26-629,213,857.07-3,213,075,922.95
四、汇率变动对现金及现金等价物的影响-19,449,773.8948,560,723.57-82,220,480.64-30,405,018.39
五、现金及现金等价物净增加额-1,701,442,746.4-543,263,359.12-901,988,704.89-2,855,201,370.05
  加:期初现金及现金等价物余额4,140,697,173.434,140,697,173.435,042,685,878.325,042,685,878.32
  期末现金及现金等价物余额2,439,254,427.033,597,433,814.314,140,697,173.432,187,484,508.27
补充资料:
  净利润1,214,913,297.1-2,273,237,462.35-
  资产减值准备37,258,101.98-56,494,387.01-
  固定资产和投资性房地产折旧128,496,667.49-248,450,001.76-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧128,496,667.49-248,450,001.76-
  无形资产摊销12,501,343.59-27,995,198.23-
  长期待摊费用摊销80,909,102.51-72,050,450.68-
  处置固定资产、无形资产和其他长期资产的损失-1,035,852.35-35,698.18-
  固定资产报废损失714,715.44-4,089,796.63-
  公允价值变动损失-25,303,376.96-172,769,034.39-
  财务费用80,691,795.69-177,221,038.08-
  投资损失-119,397,192.21--229,188,040.9-
  递延所得税-32,406,552.01--183,735,795.63-
  其中:递延所得税资产减少-37,715,281.1--85,471,405.2-
    递延所得税负债增加5,308,729.09--98,264,390.43-
  存货的减少-99,181,437.62--855,979,034.19-
  经营性应收项目的减少-788,898,631.7--1,189,904,489.71-
  经营性应付项目的增加-694,672,165.54-1,100,942,240.88-
  其他55,156,455.46-4,017,659.28-
  现金的期末余额2,439,254,427.03-4,140,697,173.43-
  减:现金的期初余额4,140,697,173.43-5,042,685,878.32-
  现金及现金等价物的净增加额-1,701,442,746.4--901,988,704.89-
公告日期2025-08-222025-04-252025-04-252024-10-25
审计意见(境内)标准无保留意见
TOP↑